Literature DB >> 3168143

Efficacy of sodium thiosulfate as a local antidote to mechlorethamine skin toxicity in the mouse.

R T Dorr1, M Soble, D S Alberts.   

Abstract

The highly vesicant nature of the alkylating anticancer agent mechlorethamine (HN2, or nitrogen mustard) requires careful i.v. technique during its administration. Skin toxicity due to HN2 extravasation is severe and typically prolonged over several months. Mouse skin toxicity studies were carried out to find a local antidote to decrease the severity of tissue damage by this agent. Intradermal (i.d.) HN2 (0.005-0.5 mg) caused dose-dependent skin ulcers in the mouse. Isotonic sodium thiosulfate Na2S2O3 (0.167 M) or hypertonic (0.34 M) Na2S2O3 (0.05 ml) given immediately after HN2 significantly reduced the mean HN2 ulceration area and the total time of ulceration. Ineffective local HN2 antidotes included hyaluronidase, hydrocortisone, and sodium chloride, all given i.d. Topical applications of DMSO, cold, and heat were also ineffective. Sodium thiosulfate is believed to chemically neutralize reactive mechlorethamine-alkylating species and thus decrease skin toxicity. Thiosulfate dosing studies showed that a molar excess of at least 200:1 (Na2S2O3:HN2) was required for significant antidotal activity. If thiosulfate treatment was delayed 4-24 h after HN2, no antidotal effects were obtained. We conclude that sodium thiosulfate can decrease the severity of local tissue damage caused by HN2. It should be considered the antidote of choice in the setting of clinical HN2 extravasations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3168143     DOI: 10.1007/bf00254235

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  11 in total

1.  PROTECTION STUDIES WITH SODIUM THIOSULFATE AGAINST METHYL BIS (BETA-CHLOROETHYL)AMINE HYDROCHLORIDE (HN2) AND ITS ETHYLENIMONIUM DERIVATIVE.

Authors:  G BONADONNA; D A KARNOFSKY
Journal:  Clin Pharmacol Ther       Date:  1965 Jan-Feb       Impact factor: 6.875

2.  The initial clinical trial of nitrogen mustard.

Authors:  A GILMAN
Journal:  Am J Surg       Date:  1963-05       Impact factor: 2.565

3.  Use of sodium thiosulfate as a neutralizing agent during regional administration of nitrogen mustard: an experimental study.

Authors:  I HATIBOGLU; E MIHICH; G E MOORE; C A NICHOL
Journal:  Ann Surg       Date:  1962-12       Impact factor: 12.969

4.  Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.

Authors:  L S GOODMAN; M M WINTROBE
Journal:  J Am Med Assoc       Date:  1946-09-21

5.  Clinical evaluation of sodium thisulfate as a systemic neutralizer of nitrogen mustard: report of 12 patients.

Authors:  G OWENS; I HATIBOGLU
Journal:  Ann Surg       Date:  1961-12       Impact factor: 12.969

6.  Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.

Authors:  E J Van Scott; J D Kalmanson
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

7.  Accidental intramuscular injection of mechlorethamine.

Authors:  O E Owen; D L Dellatorre; E J Van Scott; M R Cohen
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

8.  Kinetics of sodium thiosulfate, a cisplatin neutralizer.

Authors:  M Shea; J A Koziol; S B Howell
Journal:  Clin Pharmacol Ther       Date:  1984-03       Impact factor: 6.875

9.  Experimental model of doxorubicin extravasation in the mouse.

Authors:  R T Dorr; D S Alberts; H S Chen
Journal:  J Pharmacol Methods       Date:  1980-11

10.  Cold protection and heat enhancement of doxorubicin skin toxicity in the mouse.

Authors:  R T Dorr; D S Alberts; A Stone
Journal:  Cancer Treat Rep       Date:  1985-04
View more
  3 in total

Review 1.  Prevention and management of extravasation of cytotoxic drugs.

Authors:  G Bertelli
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

2.  Protective effect of O-phenanthroline against mechlorethamine toxicity in the rat liver slice system and in the guinea pig skin.

Authors:  U Wormser; A Nyska
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

3.  Clinically-relevant cutaneous lesions by nitrogen mustard: useful biomarkers of vesicants skin injury in SKH-1 hairless and C57BL/6 mice.

Authors:  Neera Tewari-Singh; Anil K Jain; Swetha Inturi; Carl W White; Rajesh Agarwal
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.